Error: Could not add to watchlist. X

RXi Pharmaceuticals Corp

+ Watchlist
RXII:US
NASDAQ CM
0.515
USD
0.010
1.90%
As of 20:10:00 ET on 07/03/2015.
Open
0.533
Day Range
0.503 - 0.540
Volume
737,596
Previous Close
0.525
52Wk Range
0.342 - 3.980
1 Yr Return
-82.54%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.670
Market Cap (m USD)
29.469
Shares Outstanding (m)
57.222
Price/Sales (TTM)
127.84
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
RXi Pharmaceuticals Corp. is a biotechnology company focused on discovering, developing and commercializing therapies addressing major unmet medical needs using RNAi-targeted technologies. The Company's proprietary RNA interference ("RNAi"), is a naturally occurring cellular mechanism that interferes with or silences expression of targeted disease-associated genes.
ADDRESS
60 Prescott Street
Worcester, MA 01605
United States
PHONE
1-508-767-3861
  • Geert Cauwenbergh
    President/CEO/Acting CFO
  • Pamela A Pavco
    Chief Development Officer
Show More